| Study of Apatinib in Metastatic Esophageal Cancer (NCT02683655) | Huai'an First People's Hospital | 2015-08-01 |
| Assessment of Patient Frailty Prior to Thoracic Surgery (NCT02803281) | University Health Network, Toronto | 2015-07-29 |
| Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308) (NCT02465736) | Sun Yat-sen University | 2015-07-01 |
| Pencil Beam Scanning Proton Radiotherapy for Esophageal Cancer (NCT02452021) | Mayo Clinic | 2015-07-01 |
| Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers (NCT02349412) | Alliance for Clinical Trials in Oncology | 2015-06-25 |
| HPPH Photodynamic Therapy for Patients With Esophageal Cancer (NCT03757754) | Zhejiang Hisun Pharmaceutical Co. Ltd. | 2015-06-03 |
| Tissue Collection Protocol for Gastroesophageal Cancers (NCT02495337) | University Health Network, Toronto | 2015-05-01 |
| Esophagectomy With or Without Prior Ischemic Gastric Preconditioning (NCT02457299) | Endeavor Health | 2015-05-01 |
| Pillars4Life Trial (NCT02465892) | Duke University | 2015-05-01 |
| Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer (NCT02379039) | Umeå University | 2015-05-01 |
| A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma (NCT02570893) | Zhejiang Cancer Hospital | 2015-05-01 |
| University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository (NCT02427269) | University of North Carolina, Chapel Hill | 2015-04-28 |
| PCA062 in pCAD-positive Tumors. (NCT02375958) | Novartis Pharmaceuticals | 2015-04-15 |
| Generation of a Surgical Field in the Left Lateral Decubitus Position (NCT04683601) | Shizuoka Cancer Center | 2015-04-01 |
| Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma (NCT02461043) | Chinese Academy of Medical Sciences | 2015-04-01 |
| Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium (NCT02534233) | Johns Hopkins University | 2015-04-01 |
| Efficacy of Inspiratory Muscle Training on Respiratory Performance in Patients With Esophageal Cancer Receiving Combined Modality Therapy (NCT03099629) | Mackay Memorial Hospital | 2015-03-01 |
| Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach (NCT02358863) | Georgetown University | 2015-02-01 |
| Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic Esophagectomy (NCT02320734) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-02-01 |
| Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach (NCT02448979) | Chinese Academy of Medical Sciences | 2015-01-01 |
| Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy (NCT02448966) | Chinese Academy of Medical Sciences | 2015-01-01 |
| Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer (NCT02375581) | First People's Hospital of Hangzhou | 2015-01-01 |
| Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement (NCT02448953) | Chinese Academy of Medical Sciences | 2015-01-01 |
| TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) (NCT02634645) | University of Colorado, Denver | 2015-01-01 |
| Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer Patients (NCT02323776) | Maastricht Radiation Oncology | 2014-12-01 |
| Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy (NCT02324881) | Vanderbilt-Ingram Cancer Center | 2014-12-01 |
| KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer (NCT02205463) | NYU Langone Health | 2014-12-01 |
| Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer (NCT02347904) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2014-12-01 |
| Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus (NCT02283359) | H. Lee Moffitt Cancer Center and Research Institute | 2014-12-01 |
| hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse (NCT02960594) | Inovio Pharmaceuticals | 2014-12-01 |
| LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma (NCT02138929) | M.D. Anderson Cancer Center | 2014-11-10 |
| Routine Post-Operative Supplemental Nutrition (NCT02297607) | University of Michigan | 2014-11-01 |
| The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION) (NCT02273713) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2014-10-01 |
| Rehabilitative Strategies Following Oesophageal Cancer (NCT03314311) | University of Dublin, Trinity College | 2014-10-01 |
| Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma (NCT02279134) | Zefen Xiao | 2014-10-01 |
| Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer (NCT02318901) | Western Regional Medical Center | 2014-10-01 |
| Standard Follow-Up Program (SFP) for Patients With Esophageal Cancer (NCT02454790) | University Medical Center Groningen | 2014-09-01 |
| A Study of Patient-reported Outcomes in Patients With Lung or Esophageal Cancer (NCT02239328) | University of Virginia | 2014-08-01 |
| 4D FDG PET in Esophageal Cancer (NCT02424864) | The Netherlands Cancer Institute | 2014-08-01 |
| Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer (NCT02762474) | Tianjin Medical University Cancer Institute and Hospital | 2014-07-01 |
| POsitioning for Esophageal Cancer Resection (NCT02157363) | Technische Universität Dresden | 2014-06-16 |
| Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment (NCT02274012) | Columbia University | 2014-05-29 |
| Organ Motion and Early Tumor Response Measurement (NCT02139488) | The Netherlands Cancer Institute | 2014-04-18 |
| Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer (NCT02213497) | Abramson Cancer Center at Penn Medicine | 2014-04-01 |
| Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation (NCT01627080) | M.D. Anderson Cancer Center | 2014-04-01 |
| VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions (NCT02129933) | University Medical Center Groningen | 2014-04-01 |
| Prospective Analysis of Robot-Assisted Surgery (NCT02292914) | Instituto do Cancer do Estado de São Paulo | 2014-03-10 |
| Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer (NCT01998230) | Yin Li | 2014-02-01 |
| Postoperative Pain Management After Minimally Invasive Esophagectomy (NCT02042313) | Sun Yat-sen University | 2014-02-01 |
| Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer (NCT01998347) | Shantou University Medical College | 2013-11-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| PReoperative Identification Of Response to Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NCT02125448) | Gert Meijer | 2013-10-01 |
| Balloon Dilation to Permit Complete Endoscopic Ultrasound Staging in Esophageal Cancer (NCT01950442) | Centre hospitalier de l'Université de Montréal (CHUM) | 2013-10-01 |
| ESI With EUS to Differentiate T3 and T4 ESCC (NCT01930630) | Sun Yat-sen University | 2013-10-01 |
| Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer (NCT03120572) | Mackay Memorial Hospital | 2013-08-01 |
| Iron Replacement in Oesophagogastric Neoplasia (NCT01927328) | Nottingham University Hospitals NHS Trust | 2013-08-01 |
| FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer (NCT01913639) | Memorial Sloan Kettering Cancer Center | 2013-07-01 |
| BKM120 in Esophageal Squamous Cell Carcinoma After Failure of First Line Chemotherapy (NCT01806649) | Prince of Songkla University | 2013-07-01 |
| Circumferential Section Pane Less Than 1 mm in Esophagectomy for Esophageal Cancer. (NCT01959906) | University Hospital, Gasthuisberg | 2013-07-01 |
| Age and Gender Corrected Body Mass Index (NCT01958697) | University Hospital, Gasthuisberg | 2013-07-01 |
| NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer (NCT01808417) | Dana-Farber Cancer Institute | 2013-06-21 |
| Endoscopic Prevention of Esophageal Cancer at Tenwek Hospital (NCT02146508) | Tenwek Hospital | 2013-06-01 |
| Spray Cryotherapy for Esophageal Cancer (ICE-CANCER) (NCT01868139) | University of Maryland, Baltimore | 2013-06-01 |
| Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected During Staging of Esophageal Cancer Patients (NCT02221245) | University of Miami | 2013-04-05 |
| A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer (NCT01746043) | M.D. Anderson Cancer Center | 2013-02-01 |
| Quality of Life After Esophagectomy for Cancer - Step 1 (NCT01738620) | University of Padova | 2013-01-01 |
| Influence of Hospital Volume on Mortality and Length of Hospital Stay After Oesophageal Cancer Resection in Switzerland (NCT07022652) | Cantonal Hospital of St. Gallen | 2013-01-01 |
| Prehabilitation for Esophageal Resection Surgery (NCT01666158) | Franco Carli | 2013-01-01 |
| Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer (NCT01843049) | Fudan University | 2013-01-01 |
| FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer (NCT01747551) | Dana-Farber Cancer Institute | 2013-01-01 |
| Assessment of a Modified Minimally Invasive Esophagectomy (NCT04219410) | Kaiser Permanente | 2013-01-01 |
| Quality of Life After Esophagectomy for Cancer - Step 2 (NCT01738633) | University of Padova | 2013-01-01 |
| Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer (NCT01631552) | Gilead Sciences | 2012-12-17 |
| Comparison of O-type Hybrid Knife and IT Knife in ESD (NCT01760070) | Xijing Hospital of Digestive Diseases | 2012-12-01 |
| Using "PET Response Criteria in Solid Tumors (PERCIST)" in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal Cancer (NCT01927978) | National Taiwan University Hospital | 2012-10-01 |
| CT Perfusion Changes in GI Cancer During Adenosine Vasodilation Test (NCT02074124) | University of Copenhagen | 2012-10-01 |
| Genomic Study of Relapse Esophageal Cancer After Radiotherapy (NCT04694391) | Fudan University | 2012-09-14 |
| Mithramycin for Lung, Esophagus, and Other Chest Cancers (NCT01624090) | National Cancer Institute (NCI) | 2012-09-06 |
| Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer (NCT01691664) | Capital Medical University | 2012-09-01 |
| Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer (NCT01704690) | Peking University | 2012-08-01 |
| Perspectives of Receiving Open Versus Minimally Invasive Surgery (NCT01807390) | Ottawa Hospital Research Institute | 2012-07-01 |
| Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures (NCT01661686) | Foundation for Liver Research | 2012-07-01 |
| Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer Patient (NCT01952210) | National Taiwan University Hospital | 2012-06-01 |
| Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus (NCT01447927) | National Cancer Institute (NCI) | 2012-06-01 |
| In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study (NCT01995084) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2012-05-01 |
| Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival (NCT02055313) | Meir Medical Center | 2012-05-01 |
| Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial (NCT01512589) | M.D. Anderson Cancer Center | 2012-04-30 |
| Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy (NCT01544790) | UMC Utrecht | 2012-04-01 |
| Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer (NCT01558648) | Memorial Sloan Kettering Cancer Center | 2012-03-14 |
| Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma (NCT01824966) | University Hospital, Gasthuisberg | 2012-03-01 |
| Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer (NCT01522768) | Memorial Sloan Kettering Cancer Center | 2012-03-01 |
| Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer (NCT01490749) | Emory University | 2012-02-01 |
| Endoscopic Ultrasound Plus Submucosal Injection for Early Esophageal Cancer (NCT01555801) | Sun Yat-sen University | 2012-02-01 |
| Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis Esophagectomy (NCT01551433) | Memorial Sloan Kettering Cancer Center | 2012-02-01 |
| S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer (NCT01498289) | SWOG Cancer Research Network | 2012-02-01 |
| Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer (NCT01551641) | Changzhou No.2 People's Hospital | 2012-01-01 |
| Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis (NCT01525953) | Centre Oscar Lambret | 2012-01-01 |
| Decreasing Postoperative Complications by Goal-Directed Fluid Therapy During Esophageal Resection (NCT01416077) | University Hospital, Linkoeping | 2011-10-01 |
| Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer (NCT01463501) | Zhejiang Cancer Hospital | 2011-10-01 |
| Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia (NCT01444456) | Amgen | 2011-10-01 |